Congrats to Argentina, Argentina have approved Spinraza for all SMA types without limitations, hurray. These children, adults get the chance for a better life.
In the next few days comes the management plan. This is a historically victory. Rich country like Denmark, which still refuses therapy for its patients.
All of Scandinavia countries has an age restriction.
Argentina can be proud of itself
Countries like Denmark (only for SMA type 1, SMA type 2 under 6 age,
Norway (SMA typ1)
Sweden all SMA patients, but only under 18 years.
In Europe, there are few countries like Germany that have all SMA Patients access to Spinraza, without any age limit.